Assessment of Two Commercial Comprehensive Gene Panels for Personalized Cancer Treatment

Assessment of Two Commercial Comprehensive Gene Panels for Personalized Cancer Treatment

(1) Background: Analysis of tumor DNA by next-generation sequencing (NGS) plays various roles in the classification and management of cancer. This study aimed to assess the performance of two similar and large, comprehensive gene panels with a focus on clinically relevant variant detection and tumor...

Full description

Bibliographic Details
Main Authors:	Anine Larsen Ottestad, Mo Huang, Elisabeth Fritzke Emdal, Robin Mjelle, Veronica Skarpeteig, Hong Yan Dai
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Series:	Journal of Personalized Medicine
Subjects:	next-generation sequencing comprehensive cancer panel personalized treatment
Online Access:	https://www.mdpi.com/2075-4426/13/1/42

Similar Items

Inter-assay variability of next-generation sequencing-based gene panels
by: Pham Nguyen Quy, et al.
Published: (2022-04-01)

Analysis of quality metrics in comprehensive cancer genomic profiling using a dual DNA–RNA panel
by: Kousuke Watanabe, et al.
Published: (2024-03-01)

Clinical application of comprehensive genomic profiling panel to thoracic malignancies: A single‐center retrospective study
by: Kei Kunimasa, et al.
Published: (2022-11-01)

Comprehensive analysis of germline mutations in northern Brazil: a panel of 16 genes for hereditary cancer-predisposing syndrome investigation
by: Amanda Ferreira Vidal, et al.
Published: (2021-04-01)

Usefulness of comprehensive targeted multigene panel sequencing for neuromuscular disorders in Korean patients
by: Jihye Park, et al.
Published: (2019-10-01)

Comprehensive Development and Implementation of Good Laboratory Practice for NGS Based Targeted Panel on Solid Tumor FFPE Tissues in Diagnostics
by: Anuradha Chougule, et al.
Published: (2022-05-01)

Comprehensive NGS Panel Validation for the Identification of Actionable Alterations in Adult Solid Tumors
by: Paula Martínez-Fernández, et al.
Published: (2021-04-01)

Validation of targeted next-generation sequencing panels in a cohort of Polish patients with epilepsy: assessing variable performance across clinical endophenotypes and uncovering novel genetic variants
by: Magdalena Badura-Stronka, et al.
Published: (2024-01-01)

Exome sequencing and targeted gene panels: a simulated comparison of diagnostic yield using data from 158 patients with rare diseases
by: Caio Robledo D’Angioli Costa Quaio, et al.
Published: (2021-09-01)

Pleural cryobiopsy is useful for comprehensive cancer genetic panel testing
by: Satoru Ishii, et al.
Published: (2020-07-01)

Genetic screening of a Chinese cohort of children with hearing loss using a next-generation sequencing panel
by: Jing Ma, et al.
Published: (2023-01-01)

A comprehensive custom panel evaluation for routine hereditary cancer testing: improving the yield of germline mutation detection
by: Carolina Velázquez, et al.
Published: (2020-06-01)

Helpful Criteria When Implementing NGS Panels in Childhood Lymphoblastic Leukemia
by: Nerea Vega-Garcia, et al.
Published: (2020-11-01)

Correction: Associations between detectable circulating tumor DNA and tumor glucose uptake measured by 18F-FDG PET/CT in early-stage non-small cell lung cancer
by: Anine Larsen Ottestad, et al.
Published: (2023-07-01)

Associations between detectable circulating tumor DNA and tumor glucose uptake measured by 18F-FDG PET/CT in early-stage non-small cell lung cancer
by: Anine Larsen Ottestad, et al.
Published: (2023-07-01)

High Performance of a Dominant/X-Linked Gene Panel in Patients with Neurodevelopmental Disorders
by: Nino Spataro, et al.
Published: (2023-03-01)

Validation of Customized Cancer Panel for Detecting Somatic Mutations and Copy Number Alterations
by: Su-Hye Choi, et al.
Published: (2017-12-01)

Molecular residual disease detection in resected, muscle-invasive urothelial cancer with a tissue-based comprehensive genomic profiling–informed personalized monitoring assay
by: Thomas Powles, et al.
Published: (2023-07-01)

Molecular Diagnosis of Panel-Based Next-Generation Sequencing Approach and Clinical Symptoms in Patients With Glycogen Storage Disease: A Single Center Retrospective Study
by: Shen Ying, et al.
Published: (2020-12-01)

Using gene panels in the diagnosis of neuromuscular disorders: A mini-review
by: Kay W. P. Ng, et al.
Published: (2022-10-01)

Molecular Diagnostic of Solid Tumor Using a Next Generation Sequencing Custom-Designed Multi-Gene Panel
by: Dario de Biase, et al.
Published: (2020-04-01)

Molecular Genetic Profile of 300 Japanese Patients with Diffuse Gliomas Using a Glioma-tailored Gene Panel
by: Nayuta HIGA, et al.
Published: (2022-09-01)

Multi-gene panel testing and association analysis in Cypriot breast cancer cases and controls
by: Maria Zanti, et al.
Published: (2023-09-01)

Development and validation of next generation sequencing based 35-gene hereditary cancer panel
by: Wing Chan, et al.
Published: (2020-04-01)

Comprehensive genomic evaluation of advanced and recurrent breast cancer patients for tailored precision treatments
by: Mirai Ido, et al.
Published: (2024-01-01)

Molecular Characterization of Somatic Alterations in Dukes’ B and C Colorectal Cancers by Targeted Sequencing
by: Shafina-Nadiawati Abdul, et al.
Published: (2017-07-01)

A Computational Framework for Comprehensive Genomic Profiling in Solid Cancers: The Analytical Performance of a High-Throughput Assay for Small and Copy Number Variants
by: Luciano Giacò, et al.
Published: (2022-12-01)

Novel inactivating follicle-stimulating hormone receptor mutations in a patient with premature ovarian insufficiency identified by next-generation sequencing gene panel analysis
by: Asma Sassi, M.D., et al.
Published: (2020-12-01)

Novel next generation sequencing panel method for the multiple detection and identification of foodborne pathogens in agricultural wastewater
by: Dong-Geun Park, et al.
Published: (2023-07-01)

Rapid detection by hydrops panel of Noonan syndrome with PTPN11 mutation (p.Thr73Ile) and persistent thrombocytopenia
by: Mascha Schönfeld, et al.
Published: (2020-05-01)

Dry Panels Supporting External Quality Assessment Programs for Next Generation Sequencing-Based HIV Drug Resistance Testing
by: Marc Noguera-Julian, et al.
Published: (2020-06-01)

Six years’ experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias
by: Jacqueline S. Dron, et al.
Published: (2020-02-01)

Mutation Analysis of Consanguineous Moroccan Patients with Parkinson’s Disease Combining Microarray and Gene Panel
by: Ahmed Bouhouche, et al.
Published: (2017-10-01)

Application of targeted panel sequencing and whole exome sequencing for 76 Chinese families with retinitis pigmentosa
by: Handong Dan, et al.
Published: (2020-03-01)

Clinicopathologic and genomic characterizations of brain metastases using a comprehensive genomic panel
by: Duna H. Barakeh, et al.
Published: (2022-11-01)

Targeted Next-Generation Sequencing-Based Multiple Gene Mutation Profiling of Patients with Rectal Adenocarcinoma Receiving or Not Receiving Neoadjuvant Chemoradiotherapy
by: You-Kang Chang, et al.
Published: (2022-09-01)

Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI)
by: Irene Vanni, et al.
Published: (2020-12-01)

A comprehensive DNA panel next generation sequencing approach supporting diagnostics and therapy prediction in neurooncology
by: Julia Lorenz, et al.
Published: (2020-08-01)

Molecular Targets in Salivary Gland Cancers: A Comprehensive Genomic Analysis of 118 Mucoepidermoid Carcinoma Tumors
by: Maroun Bou Zerdan, et al.
Published: (2023-02-01)

Preparation of the standard cell lines for reference mutations in cancer gene-panels by genome editing in HEK 293 T/17 cells
by: Takayoshi Suzuki, et al.
Published: (2020-02-01)